Shlomi Matetzky

5.7k total citations · 1 hit paper
158 papers, 3.8k citations indexed

About

Shlomi Matetzky is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Shlomi Matetzky has authored 158 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Cardiology and Cardiovascular Medicine, 56 papers in Surgery and 36 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Shlomi Matetzky's work include Acute Myocardial Infarction Research (71 papers), Cardiac Imaging and Diagnostics (36 papers) and Antiplatelet Therapy and Cardiovascular Diseases (36 papers). Shlomi Matetzky is often cited by papers focused on Acute Myocardial Infarction Research (71 papers), Cardiac Imaging and Diagnostics (36 papers) and Antiplatelet Therapy and Cardiovascular Diseases (36 papers). Shlomi Matetzky collaborates with scholars based in Israel, United States and Malaysia. Shlomi Matetzky's co-authors include Hanoch Hod, Michael Shechter, Ilya Novikov, Ilan Goldenberg, Victor Guetta, Roy Beinart, David Varon, Naphtali Savion, Б. С. Шенкман and Dov Freimark and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Shlomi Matetzky

149 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction

2004 1.0k citations Shlomi Matetzky, Victor Guetta et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shlomi Matetzky Israel	29	3.0k	1.3k	813	516	262	158	3.8k
Madhu K. Natarajan Canada	30	3.5k 1.2×	2.0k 1.5×	733 0.9×	683 1.3×	155 0.6×	128	4.7k
David J. Moliterno United States	39	5.7k 1.9×	3.1k 2.3×	1.5k 1.9×	1.3k 2.4×	270 1.0×	100	6.6k
Rikke Sørensen Denmark	27	2.3k 0.8×	650 0.5×	211 0.3×	619 1.2×	160 0.6×	91	3.9k
Anatoly Langer Canada	39	4.8k 1.6×	2.2k 1.6×	1.6k 2.0×	1.2k 2.3×	527 2.0×	159	6.3k
Marcello Galvani Italy	27	2.6k 0.9×	843 0.6×	1.2k 1.4×	230 0.4×	109 0.4×	100	3.6k
Paul DeLucca United States	18	2.6k 0.9×	1.4k 1.0×	913 1.1×	255 0.5×	155 0.6×	24	3.5k
Jan Kyst Madsen Denmark	28	3.2k 1.1×	1.4k 1.1×	1.4k 1.7×	277 0.5×	153 0.6×	109	4.2k
Magnus Öhman United States	15	4.8k 1.6×	2.0k 1.5×	1.8k 2.2×	517 1.0×	257 1.0×	21	6.2k
Richard Whitlock Canada	37	3.2k 1.0×	1.6k 1.2×	288 0.4×	424 0.8×	157 0.6×	237	4.8k
Steven Borzak United States	31	2.2k 0.7×	707 0.5×	574 0.7×	333 0.6×	76 0.3×	82	3.2k

Countries citing papers authored by Shlomi Matetzky

Since Specialization

Citations

This map shows the geographic impact of Shlomi Matetzky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shlomi Matetzky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shlomi Matetzky more than expected).

Fields of papers citing papers by Shlomi Matetzky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shlomi Matetzky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shlomi Matetzky. The network helps show where Shlomi Matetzky may publish in the future.

Co-authorship network of co-authors of Shlomi Matetzky

This figure shows the co-authorship network connecting the top 25 collaborators of Shlomi Matetzky. A scholar is included among the top collaborators of Shlomi Matetzky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shlomi Matetzky. Shlomi Matetzky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karra, Nour, Paul Fefer, Elad Maor, et al.. (2024). Temporal Trends in Patient Characteristics and Clinical Outcomes of TAVR: Over a Decade of Practice. Journal of Clinical Medicine. 13(17). 5027–5027. 2 indexed citations

Matetzky, Shlomi, Romana Herscovici, Ronen Goldkorn, et al.. (2023). Sex differences of patients with acute chest pain evaluated through a chest pain unit. Journal of Cardiovascular Medicine. 24(5). 283–288. 1 indexed citations

Brodov, Yafim, Shlomi Matetzky, Eli Konen, et al.. (2022). Elevated Native T1 Values in the Remote Myocardium Supplied by Obstructive Non-Infarct Related Coronary Arteries in Post-STEMI Cardiac Magnetic Resonance. Cardiology. 148(2). 106–113.

Oren, Daniel, Orly Goitein, Yafim Brodov, et al.. (2022). Post–ST‐Segment–Elevation Myocardial Infarction Platelet Reactivity Is Associated With the Extent of Microvascular Obstruction and Infarct Size as Determined by Cardiac Magnetic Resonance Imaging. Journal of the American Heart Association. 11(3). e020973–e020973. 11 indexed citations

Fishman, Boris, Orly Goitein, Anat Berkovitch, Galia Rahav, & Shlomi Matetzky. (2022). First report of myocarditis in two patients with COVID-19 Omicron variant: case report. European Heart Journal - Case Reports. 6(10). ytac407–ytac407. 9 indexed citations

Mouallem, Meir, Paul Fefer, Israel M. Barbash, et al.. (2022). Management and outcome of patients with non-ST elevation myocardial infarction and intercurrent non-coronary precipitating events. European Heart Journal Acute Cardiovascular Care. 11(12). 922–930. 3 indexed citations

Hadanny, Amir, Roni Shouval, Jianhua Wu, et al.. (2021). Machine learning-based prediction of 1-year mortality for acute coronary syndrome✰. Journal of Cardiology. 79(3). 342–351. 11 indexed citations

Fardman, Alexander, Doron Zahger, Katia Orvin, et al.. (2021). Acute myocardial infarction in the Covid-19 era: Incidence, clinical characteristics and in-hospital outcomes—A multicenter registry. PLoS ONE. 16(6). e0253524–e0253524. 36 indexed citations

Lotan, Dor, Shlomi Matetzky, Jason D. Perlmutter, et al.. (2020). SAFETY AND EFFICACY OF TICAGRELOR IN CAROTID ARTERY ANGIOPLASTY IN PATIENTS WITH CLOPIDOGREL RESISTANCE: REAL LIFE EXPERIENCE. Journal of the American College of Cardiology. 75(11). 1302–1302. 2 indexed citations

10.

Vilchinsky, Noa, et al.. (2018). Cardiac-disease-induced PTSD and Fear of illness progression: Capturing the unique nature of disease-related PTSD. General Hospital Psychiatry. 53. 131–138. 30 indexed citations

11.

Asher, Elad, et al.. (2018). Acute myocardial infarction occurring while on chronic clopidogrel therapy (‘clopidogrel failure’) is associated with high incidence of clopidogrel poor responsiveness and stent thrombosis. PLoS ONE. 13(4). e0195504–e0195504. 1 indexed citations

12.

Asher, Elad, Avi Sabbag, Ronen Goldkorn, et al.. (2018). Differentiating Takotsubo cardiomyopathy from ST-segment elevation myocardial infarction. Hong Kong Journal of Emergency Medicine. 26(4). 203–208. 2 indexed citations

13.

Kalter‐Leibovici, Ofra, Dov Freimark, Laurence S. Freedman, et al.. (2017). Disease management in the treatment of patients with chronic heart failure who have universal access to health care: a randomized controlled trial. BMC Medicine. 15(1). 90–90. 51 indexed citations

14.

Koifman, Edward, Roy Beigel, Romana Herscovici, et al.. (2016). Immediate response to prasugrel loading in patients with ST-elevation myocardial infarction: Predictors and outcome. Thrombosis Research. 144. 176–181. 1 indexed citations

15.

Beigel, Roy, Zaza Iakobishvili, Shlomo Nir, et al.. (2016). Real-World Use of Novel P2Y12 Inhibitors in Patients with Acute Myocardial Infarction: A Treatment Paradox. Cardiology. 136(1). 21–28. 19 indexed citations

16.

Beigel, Roy, Orly Goitein, Pierre Chouraqui, et al.. (2010). Fast track evaluation of patients with acute chest pain: experience in a large-scale chest pain unit in Israel.. PubMed. 12(6). 329–33. 7 indexed citations

17.

Shechter, Michael, Shlomi Matetzky, Michael Arad, Micha S. Feinberg, & Dov Freimark. (2009). Vascular Endothelial Function Predicts Mortality Risk in Patients with Advanced Ischaemic Chronic Heart Failure. European Journal of Heart Failure. 11(6). 588–593. 80 indexed citations

18.

Fefer, Paul, Hanoch Hod, Jacob Ilany, et al.. (2008). Comparison of Myocardial Reperfusion in Patients With Fasting Blood Glucose ≤100, 101 to 125, and >125 mg/dl and ST-Elevation Myocardial Infarction With Percutaneous Coronary Intervention. The American Journal of Cardiology. 102(11). 1457–1462. 9 indexed citations

19.

Shenkman, Boris, Shlomi Matetzky, Paul Fefer, et al.. (2008). Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests. Thrombosis Research. 122(3). 336–345. 41 indexed citations

20.

Barsheshet, Alon, Hanoch Hod, Michael Shechter, et al.. (2007). The Effects of External Counter Pulsation Therapy on Circulating Endothelial Progenitor Cells in Patients with Angina Pectoris. Cardiology. 110(3). 160–166. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact